Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 3401 - 500 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
Reset 

Abzena Announces Major Investment in Bioconjugation and ADC Capabilities in Response to Increasing Industry Demand

Read more ››
By: PR Newswire Association LLC. - 27 Mar 2024
Related companies:  Abzena Ltd

In Vitro Diagnostics Market Worth $119.4 billion | MarketsandMarkets™

Read more ››
By: PR Newswire Association LLC. - 27 Mar 2024

Inhaled Nitric Oxide Market Projected to Reach $1,157.38 million by 2030 - Exclusive Report by 360iResearch

Read more ››
By: PR Newswire Association LLC. - 27 Mar 2024

Middle East and Africa Nutraceuticals Market Report 2023: Regional and Country Level Analysis to 2033 - Evolving Consumer Preferences and a Growing Awareness of the Importance of Health and Wellness

Read more ››
By: PR Newswire Association LLC. - 27 Mar 2024

Companion Diagnostic Market Research Report 2024 with Executive and Consultant Guides

Read more ››
By: PR Newswire Association LLC. - 27 Mar 2024

Sterile & Antiviral Packaging Market to Hit US$42.8 Billion by 2034, Driven By Rising Medical Procedures and Implant Tech

Read more ››
By: PR Newswire Association LLC. - 27 Mar 2024

Global Arthroscopy Devices Market Analysis 2024-2034, Featuring Johnson & Johnson, Arthrex, Zimmer Biomet, Medtronic, Richard Wolf, Conmed, Stryker, Smith + Nephew, Henke Sass Wolf and Karl Storz

Read more ››
By: PR Newswire Association LLC. - 27 Mar 2024

YolTech Therapeutics to Participate in 2024 Cell & Gene Meeting on the Mediterranean

Read more ››
By: PR Newswire Association LLC. - 27 Mar 2024

Overcoming EU IVDR Challenges When Using Clinical Trial Assays to Accelerate Global CDx Trials, Upcoming Webinar Hosted by Xtalks

Read more ››
By: PR Newswire Association LLC. - 27 Mar 2024
Related companies:  Xtalks

Olympus Canada Announces Expansion of Single-Use ENT Product Line

Read more ››
By: PR Newswire Association LLC. - 27 Mar 2024

MediPharm Labs Provides Conference Call Recording Details

Read more ››
By: PR Newswire Association LLC. - 27 Mar 2024
Related companies:  MediPharm Labs Corp.

Medline Canada introduces the Physician Partner Program supporting practice management and patient care

Read more ››
By: PR Newswire Association LLC. - 27 Mar 2024

Statement from the Chief Public Health Officer of Canada Update on Measles and Risk to Canadians

Read more ››
By: PR Newswire Association LLC. - 27 Mar 2024

Vidac Pharma receives Japanese Patent Office Notice of Allowance for VDA-1275 cancer drug candidate

Read more ››
By: GlobeNewswire - 27 Mar 2024

Sosei Heptares Confirms Re-election of its Board and Executive Management Team and the Approval of Change of Company Name to Nxera Pharma

Read more ››
By: GlobeNewswire - 27 Mar 2024
Related companies:  Nxera Pharma Co., Ltd.

Convening of the ordinary general meeting of shareholders of April 26, 2024

Read more ››
By: GlobeNewswire - 27 Mar 2024

XORTX Announces New Clinical Advisory Board Member

Read more ››
By: GlobeNewswire - 27 Mar 2024
Related companies:  XORTX Therapeutics Inc

Zymeworks Announces Participation in Upcoming Investor Conferences

Read more ››
By: GlobeNewswire - 27 Mar 2024
Related companies:  Zymeworks Inc.

BiomX to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast on April 3rd, 2024

Read more ››
By: GlobeNewswire - 27 Mar 2024
Related companies:  BiomX Inc.

ANI Pharmaceuticals Announces the Launch of Levofloxacin Oral Solution, USP

Read more ››
By: GlobeNewswire - 27 Mar 2024
Related companies:  ANI Pharmaceuticals, Inc.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
to the top ↑